Faculty

Institution

Unit

Venue

H. Charles Manning

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Cancer Medicine

Division Of Diagnostic Imaging

Department Of Cancer Systems Imaging

The University of Texas MD Anderson Cancer Center

H. Charles Manning is currently serving as a Cancer Medicine Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

H. Charles Manning

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

pharmacology oncology cancer research cancer imaging molecular imaging radiation oncology medical imaging cancer biology tumor biology biomedical imaging health sciences medicinal research cell biology tumor targeting cancer treatment colorectal cancer nuclear medicine molecular cancer positron emission tomography therapeutic targets cancer care breast cancer oncogenes oncologic imaging drug discovery cancer cells photomedicine therapeutic imaging radiopharmaceutical therapy enzyme inhibition pharmacotherapy cancer discovery brain tumor research anti-cancer agents translational molecular imaging preclinical models cell metabolism pharmaceutical chemistry magnetic resonance imaging drug targeting cancer growth cancer genetics pet imaging protein science breast oncology treatment development cancer genomics hormonal receptor brain imaging high-throughput screening computed tomography glutamine metabolism vascular biology endocrine-related cancers inhibitory activity cancer management metastatic colorectal cancer preclinical evaluation translocator protein bioconjugation genitourinary cancers pharmaceutical sciences glycosylation protein expression imaging agent benchmark studies microwave-assisted organic synthesis ras wildtype tumor cells cell-programmed nutrient partitioning acetate dependence pharmacological blockade posttranslational up-regulation triple-negative breast cancer early-treatment response optical metabolic

Notable Scholarly Works

Notable Federal Grants

Collaborators

177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. Molecular Cancer Therapeutics (2025)

Aiko YamaguchiChisato M. YamazakiYasuaki AnamiSummer Y. Y. HaWei XiongRobert T. TaNingyan ZhangH. Charles ManningZhiqiang AnKyoji Tsuchikama

cancer immunotherapytherapeutic targetstumor biologyoncologycancer researchcancer treatmentcancer discoveryantibody engineeringmolecular cancernovel therapiesimmunologytumor targetingmedicinal researchsolid tumorsbiomolecular engineeringoncogenesmolecular biologypharmacotherapytreatment development

Democratizing Radiopharmaceutical Production: The Rapid Chip. (2025)

science and technology studiesradiopharmaceutical therapyscientific communicationtechnologyrapid chipfine chemicalsnuclear medicine

Determining the Metabolic Landscape of Pancreatic Cancer With Pharmacological Blockade of the Glutamine Transporter, Asct2. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition (2025)

metabolic pathwaysmetabolismmolecular metabolismglutamine transportercancer researchpharmacological researchmolecular cancermetabolic remodelingcancer cellspancreatic cancerbiochemistrypharmacologymetabolic landscapecell metabolism

Radiotheranostic Landscape: A Review of Clinical and Preclinical Development. European Journal of Nuclear Medicine and Molecular Imaging (2025)

cancer imagingradiation therapyradiation oncologyradiotheranostic landscaperadiation

Reproducibility and Repeatability of 18F-(2S, 4R)-4-Fluoroglutamine Pet Imaging in Preclinical Oncology Models. PLoS ONE (2025)

biomedical imagingcancer imagingradiation oncologymolecular imagingoncologic imaging-4-fluoroglutamine pet imagingfunctional imagingpositron emission tomographyradiologypreclinical oncology modelsmedical imagingnuclear medicine

Supplementary Data1 From Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic Lesions. (2025)

biomedical imagingcancer imagingoncologymolecular imagingoncologic imagingpancreatic cancersupplementary data1radiologytumor microenvironmentpathology

Supplementary Methods 1 From Results of the Phase I/II Study and Preliminary B-Cell Gene Signature of Combined Inhibition of Glutamine Metabolism and Egfr in Colorectal Cancer. (2025)

Kristen K. CiomborSeong-Woo BaeJennifer G. WhisenantGregory D. AyersQuanhu ShengTodd E. PetersonGary T. SmithKangyu LinSaikat ChowdhuryPreeti Kanikarla MarieAlexey SorokinAllison S. CohenLaura W. GoffDana B. CardinJohn Paul ShenScott KopetzCathy EngYu ShyrJordan BerlinH. Charles Manning

glutamine metabolismtumor biologygeneticscolorectal cancermolecular metabolismcancer researchoncologymolecular cancercombined inhibitionbiochemistrymolecular biologyinhibitory activitytumor microenvironmentcancer geneticsbiomarkers

Supplementary Table S2 From Sup 177 /Sup Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. (2025)

cancer immunotherapyantibody engineeringradiation oncologylu-labeled antibody–drug conjugatecell biologycancer cellsdual-mechanistic treatment modalityimmunotherapydrug targetingtherapeutic targetstumor targetingtheranosticsjama oncologysupplementary table s2

Today’s Research, Tomorrow’s Practice – White Paper From the Translation of New Therapy (Tnt) Radiotheranostics Kick-Off Pre-Meeting of the Annual World Molecular Imaging Conference 2024. Molecular Imaging and Biology (2025)

new therapybiomedical imagingcancer imagingradiation therapyoncologyradiation oncologyradiotheranostics kick-off pre-meetingmolecular imagingradiopharmaceutical therapyoncologic imagingradiationtherapeutic imagingradiologytheranosticsphotomedicinetranslational researchmedical imaging

Passing the Molecular Imaging and Biology Torch. Molecular Imaging and Biology (2024)

biophysicsbiomedical imagingmolecular imagingtranslational molecular imagingbiological imaging

1
2
3
4
5
15
10 / page

H. Charles Manning

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Cancer Medicine

Division Of Diagnostic Imaging

Department Of Cancer Systems Imaging

The University of Texas MD Anderson Cancer Center

H. Charles Manning is currently serving as a Cancer Medicine Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

H. Charles Manning

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. Molecular Cancer Therapeutics (2025)

Aiko YamaguchiChisato M. YamazakiYasuaki AnamiSummer Y. Y. HaWei XiongRobert T. TaNingyan ZhangH. Charles ManningZhiqiang AnKyoji Tsuchikama

Democratizing Radiopharmaceutical Production: The Rapid Chip. (2025)

science and technology studiesradiopharmaceutical therapyscientific communicationtechnologyrapid chipfine chemicalsnuclear medicine

Radiotheranostic Landscape: A Review of Clinical and Preclinical Development. European Journal of Nuclear Medicine and Molecular Imaging (2025)

cancer imagingradiation therapyradiation oncologyradiotheranostic landscaperadiation

Reproducibility and Repeatability of 18F-(2S, 4R)-4-Fluoroglutamine Pet Imaging in Preclinical Oncology Models. PLoS ONE (2025)

Supplementary Data1 From Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic Lesions. (2025)

biomedical imagingcancer imagingoncologymolecular imagingoncologic imagingpancreatic cancersupplementary data1radiologytumor microenvironmentpathology

Supplementary Methods 1 From Results of the Phase I/II Study and Preliminary B-Cell Gene Signature of Combined Inhibition of Glutamine Metabolism and Egfr in Colorectal Cancer. (2025)

Supplementary Table S2 From Sup 177 /Sup Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. (2025)

Passing the Molecular Imaging and Biology Torch. Molecular Imaging and Biology (2024)

biophysicsbiomedical imagingmolecular imagingtranslational molecular imagingbiological imaging

1
2
3
4
5
15
10 / page